Ischaemic Heart Disease Clinical Trial
Official title:
Outcomes of Drug Coated Balloon Angioplasty, A UK Real Life Experience From 2009 to 2015
This is a single center, retrospective, observational cohort study to assess the safety and efficacy of drug coated balloon (DCB) angioplasty in all forms of coronary artery disease. The Investigators intend to report outcomes of all patients who received DCB angioplasty at their center during the above mentioned period for up to 10 years.
The Investigators expect to assess outcomes of all patients who received Drug Coated Balloon Angioplasty treatment, which is a novel therapy as opposed to standard Drug Eluting Stent insertion, for all types of coronary artery disease from 01/01/2009 till 31/12/2015 in their center. The Investigators believe the number exceeds 1000 patients. The Investigators plan to collect demographic and procedural data from their existing data base. They will request up to date follow-up events from NICOR (National Institute for Cardiovascular Outcomes Research, UK) in 2017(data ending December 2016), by which time all patientswould have had minimum of 12 months follow up. The Investigators plan to incorporate these findings to their data set and report the comprehensive outcomes. Primary end point will be major adverse cardiac outcomes (MACE) defined as a composite of death, myocardial infarction and target vessel revascularisation. Secondary end points will be acute vessel closure and target lesion revascularisation. The Investigators also have a long term plan of requesting follow-up events from NICOR for up to 10 years, so they can report on long term outcomes of drug coated balloon treatment. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04097912 -
Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
|
||
Completed |
NCT01941355 -
Trial of Rehabilitation in Phase 1 After Coronary Artery Bypass Grafting
|
N/A | |
Completed |
NCT00151658 -
Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)
|
N/A | |
Recruiting |
NCT04193475 -
Machine Learning in Quantitative Stress Echocardiography
|
||
Completed |
NCT02290262 -
SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass Grafting
|
N/A | |
Active, not recruiting |
NCT03736018 -
Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients
|
N/A | |
Completed |
NCT02849067 -
Hemodynamic Responses of Stable Ischemic Heart Disease Patients to a Comedy Session
|
N/A | |
Recruiting |
NCT05045118 -
The Impact of Structured Patient Education Material (SPEM) in Improving Clinical and Behavioural Outcomes in Home-based Cardiac Rehabilitation Program Participants: A Pilot Study
|
N/A | |
Completed |
NCT04901767 -
Coronary Artery Endothelial Dysfunction With Drug Coated Balloons
|
||
Enrolling by invitation |
NCT03674255 -
Echocardiography: Value and Accuracy at REst and STress
|
||
Active, not recruiting |
NCT03171311 -
The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER)
|
N/A | |
Recruiting |
NCT04768283 -
Cardiac Rehabilitation and Additional Physical Training in Elderly Patients After Acute Coronary Syndrome
|
N/A | |
Completed |
NCT02315001 -
Liraglutide to Improve corONary Haemodynamics During Exercise streSS
|
Phase 2 | |
Completed |
NCT01796353 -
Effects of a Comprehensive Sexual Rehabilitation Programme in Heart Patients
|
N/A | |
Recruiting |
NCT04061525 -
Motion and IntraCoronary Ecg Ischemia Development Study (MICE)
|
||
Recruiting |
NCT04674449 -
iCorMicA - Stratified Medicine in Angina
|
N/A | |
Active, not recruiting |
NCT02623140 -
BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
|
Phase 4 | |
Completed |
NCT03646097 -
Impact of Real-time Angiographic Co-registered OCT on PCI Results - the OPTICO-integration II Study
|
N/A | |
Completed |
NCT02053818 -
Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.
|
Phase 4 | |
Recruiting |
NCT04014140 -
iFR Guided Coronary Artery Bypass Grafting Surgery
|